B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 690 KRW 1.85% Market Closed
Market Cap: 433B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

Income Statement

Earnings Waterfall
BioPlus Co Ltd

Revenue
53.5B KRW
Cost of Revenue
-22.1B KRW
Gross Profit
31.4B KRW
Operating Expenses
-15.3B KRW
Operating Income
16.1B KRW
Other Expenses
1.7B KRW
Net Income
17.8B KRW

Income Statement
BioPlus Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
24 367
N/A
28 617
+17%
43 403
+52%
43 913
+1%
37 418
-15%
49 441
+32%
45 282
-8%
51 353
+13%
56 719
+10%
57 103
+1%
61 976
+9%
65 368
+5%
65 043
0%
62 248
-4%
54 581
-12%
53 479
-2%
Gross Profit
Cost of Revenue
(7 802)
(9 322)
(13 499)
(14 161)
(13 772)
(18 312)
(18 329)
(20 716)
(22 913)
(23 189)
(24 896)
(26 418)
(25 470)
(24 542)
(22 355)
(22 076)
Gross Profit
16 565
N/A
19 295
+16%
29 904
+55%
29 753
-1%
23 646
-21%
31 130
+32%
26 953
-13%
30 637
+14%
33 806
+10%
33 914
+0%
37 079
+9%
38 951
+5%
39 573
+2%
37 705
-5%
32 226
-15%
31 403
-3%
Operating Income
Operating Expenses
(4 237)
(4 394)
(6 250)
(6 595)
(5 420)
(8 861)
(8 154)
(8 999)
(8 535)
(8 753)
(9 710)
(10 521)
(11 548)
(12 787)
(13 334)
(15 274)
Selling, General & Administrative
(3 790)
(3 874)
(5 459)
(5 768)
(4 637)
(6 157)
(5 365)
(5 832)
(6 687)
(6 813)
(7 621)
(8 325)
(9 405)
(10 396)
(10 917)
(12 755)
Research & Development
(276)
(150)
(370)
(357)
(435)
(637)
(618)
(908)
(1 081)
(1 089)
(1 205)
(1 195)
(1 165)
(1 317)
(1 266)
(1 367)
Depreciation & Amortization
(171)
(170)
(222)
(271)
(348)
(502)
(606)
(694)
(768)
(833)
(895)
(1 012)
(977)
(1 074)
(1 150)
(1 152)
Other Operating Expenses
0
(199)
(199)
(198)
0
(1 564)
(1 565)
(1 565)
0
(18)
10
10
0
0
0
0
Operating Income
12 327
N/A
14 902
+21%
23 654
+59%
23 158
-2%
18 226
-21%
22 269
+22%
18 799
-16%
21 639
+15%
25 271
+17%
25 162
0%
27 369
+9%
28 430
+4%
28 026
-1%
24 919
-11%
18 892
-24%
16 129
-15%
Pre-Tax Income
Interest Income Expense
(186)
(250)
(476)
(4 476)
(2 362)
(2 243)
(1 396)
3 390
3 043
3 926
3 589
3 710
3 764
3 697
7 719
6 918
Non-Reccuring Items
0
0
1
0
(1 564)
0
0
0
(28)
0
(19)
(19)
9
9
0
0
Gain/Loss on Disposition of Assets
(3)
0
0
0
0
18
(9)
(109)
(81)
0
(78)
23
(9)
(9)
480
480
Total Other Income
(4)
(44)
(91)
(102)
(133)
(153)
(419)
(678)
(734)
(827)
585
850
950
963
(668)
(768)
Pre-Tax Income
12 134
N/A
14 608
+20%
23 088
+58%
18 579
-20%
14 168
-24%
19 892
+40%
16 976
-15%
24 241
+43%
27 471
+13%
28 261
+3%
31 446
+11%
32 994
+5%
32 740
-1%
29 579
-10%
26 424
-11%
22 759
-14%
Net Income
Tax Provision
(2 431)
(2 910)
(3 943)
(4 297)
(3 495)
(4 803)
(4 979)
(6 172)
(6 763)
(6 003)
(6 722)
(6 813)
(5 318)
(5 472)
(3 856)
(2 667)
Income from Continuing Operations
9 703
11 698
19 146
14 283
10 673
15 088
11 997
18 069
20 708
22 258
24 723
26 181
27 422
24 107
22 568
20 092
Income to Minority Interest
0
(0)
(0)
1
0
92
169
274
429
410
(87)
(1 301)
(1 841)
(2 324)
(2 555)
(2 293)
Net Income (Common)
9 703
N/A
11 698
+21%
19 146
+64%
14 284
-25%
10 673
-25%
15 180
+42%
12 165
-20%
18 343
+51%
21 137
+15%
22 668
+7%
24 636
+9%
24 880
+1%
25 581
+3%
21 783
-15%
20 013
-8%
17 799
-11%
EPS (Diluted)
174.38
N/A
840.96
+382%
1 516.51
+80%
281.25
-81%
206.02
-27%
293.24
+42%
216.39
-26%
319.79
+48%
368.51
+15%
373.48
+1%
407.3
+9%
415.01
+2%
422.18
+2%
361.55
-14%
332.22
-8%
297.4
-10%

See Also

Discover More